Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor.
Open accessAbstract
The androgen receptor (AR) remains functionally important in the development and progression of prostate cancer even when the disease seems androgen "independent." Because signal transduction by growth factor receptors increases in advanced prostate cancer and is capable of sensitizing the AR to androgen, there is considerable interest in determining the mechanisms by which signaling systems can modulate AR function. We show herein that the adaptor/scaffolding protein receptor for activated C kinase 1 (RACK1), which was previously reported to interact with the AR, modulates the tyrosine phosphorylation of AR and its interaction with the Src tyrosine kinase. We also show that down-regulation of RACK1 by short interfering RNA inhibits growth and stimulates prostate-specific antigen transcription in androgen-treated prostate cancer cells. Our results suggest that RACK1 mediates the cross-talk of AR with additional binding partners, such as Src, and facilitates the tyrosine phosphorylation and transcriptional activity of the AR.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The activity of Src on AR transactivation is modulated, at least in part, through its binding partner and associated scaffolding protein receptor for activated C kinase 1 (RACK1).
“The activity of Src on AR transactivation is modulated, at least in part, through its binding partner and associated scaffolding protein receptor for activated C kinase 1 (RACK1) (43).”
From Minireview: Alternative Activation Pathways for the Androgen Receptor in Prostate Cancer (2011) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
1 retracted
Wong, C., McNally, C., Nickbarg, E., Komm, B. S., & Cheskis, B. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192569699 · Cited by 321 · see citing works
RetractedSequence and structure-based prediction of eukaryotic protein phosphorylation sites
Blom, N., Gammeltoft, S., & Brunak, S. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3310 · Cited by 3,197 · see citing works
Dorit Ron, A., Chen, C., Caldwell, J., Jamieson, L., Orr, E., & Mochly‐Rosen, D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.839 · Cited by 723 · see citing works
Migliaccio, A., Castoria, G., Domenico, M. D., de Falco, A., Bilancio, A., Lombardi, M., Barone, M. V., Ametrano, D., Zannini, M. S., Abbondanza, C., et al. (2000) · The EMBO Journal · doi:10.1093/emboj/19.20.5406 · Cited by 672 · see citing works
Migliaccio, A., Piccolo, D., Castoria, G., Domenico, M. D., Bilancio, A., Lombardi, M., Gong, W., Beato, M., & Auricchio, F. (1998) · The EMBO Journal · doi:10.1093/emboj/17.7.2008 · Cited by 627 · see citing works
Yeh, S., Lin, H., Kang, H., Thin, T. H., Lin, M., & Chang, C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5458 · Cited by 594 · see citing works
Boonyaratanakornkit, V., Scott, M. P., Ribon, V., Sherman, L., Anderson, S. M., Maller, J. L., Miller, W. T., & Edwards, D. P. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00304-5 · Cited by 590 · see citing works
Kemppainen, J., Lane, M. V., Sar, M., & Wilson, E. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48380-9 · Cited by 430 · see citing works
Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor.
Lin, H.-K., Yeh, S., Kang, H.-Y., & Chang, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121173298 · Cited by 401 · see citing works
The RACK1 Scaffold Protein: A Dynamic Cog in Cell Response Mechanisms
McCahill, A., Warwicker, J., Bolger, G. B., Houslay, M. D., & Yarwood, S. J. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1261 · Cited by 386 · see citing works
Regulation of androgen receptor activity by tyrosine phosphorylation.
Guo, Z., Dai, B., Jiang, T., Xu, K., Xie, Y., Kim, O., Nesheiwat, I., Kong, X., Melamed, J., Handratta, V. D., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.021 · Cited by 364 · see citing works
Androgen Receptor Phosphorylation
Gioeli, D. G., Ficarro, S. B., Kwiek, J. J., Aaronson, D. S., Hancock, M., Catling, A. D., White, F. M., Christian, R. E., Settlage, R. E., Shabanowitz, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204131200 · Cited by 355 · see citing works
Self-citationRack1, a Receptor for Activated Protein Kinase C, Interacts with Integrin β Subunit
Liliental, J., & Chang, D. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2379 · Cited by 346 · see citing works
Yarwood, S. J., Steele, M. R., Scotland, G., Houslay, M. D., & Bolger, G. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.14909 · Cited by 306 · see citing works
Nuclear receptors: integration of multiple signalling pathways through phosphorylation
Rochette-Egly, C. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00115-8 · Cited by 291 · see citing works
Tyagi, R. K., Lavrovsky, Y., Ahn, S., Song, C. S., Chatterjee, B., & Roy, A. K. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.8.0497 · Cited by 291 · see citing works
Nuclear import of the human androgen receptor
Jenster, G. W., Trapman, J., & Brinkmann, A. O. (1993) · Biochemical Journal · doi:10.1042/bj2930761 · Cited by 273 · see citing works
Chang, B. Y., Conroy, K. B., Machleder, E. M., & Cartwright, C. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3245 · Cited by 260 · see citing works
Physiological role for the cochaperone FKBP52 in androgen receptor signaling
Cheung-Flynn, J., Prapapanich, V., Cox, M. B., Riggs, D. L., Suarez-Quian, C., & Smith, D. F. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0071 · Cited by 212 · see citing works
Hermanto, U., Zong, C. S., Li, W., & Wang, L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2345-2365.2002 · Cited by 204 · see citing works
Georget, V., Lobaccaro, J. A., Térouanne, B., Mangeat, P. H., Nicolas, J., & Sultan, C. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)04034-3 · Cited by 193 · see citing works
Binding Specificity for RACK1 Resides in the V5 Region of βII Protein Kinase C
Stebbins, E. G., & Mochly‐Rosen, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101044200 · Cited by 183 · see citing works
Chang, B. Y., Chiang, M., & Cartwright, C. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101375200 · Cited by 177 · see citing works
Characterization of the Interactions of Estrogen Receptor and MNAR in the Activation of cSrc
Barletta, F., Wong, C.-W., McNally, C., Komm, B. S., Katzenellenbogen, B. S., & Cheskis, B. J. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0335 · Cited by 175 · see citing works
Stress Kinase Signaling Regulates Androgen Receptor Phosphorylation, Transcription, and Localization
Gioeli, D. G., Black, B. E., Gordon, V. L., Spencer, A., Kesler, C. T., Eblen, S. T., Paschal, B. M., & Weber, M. J. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0351 · Cited by 175 · see citing works
Self-citationContribution of the Androgen Receptor to Prostate Cancer Predisposition and Progression
Buchanan, G., Irvine, R. A., Coetzee, G. A., & Tilley, W. D. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1015531326689 · Cited by 165 · see citing works
Recent advances in androgen receptor action
Lee, H.-J., & Chang, C. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-2309-3 · Cited by 162 · see citing works
Hsp90 as a therapeutic target in prostate cancer
Solit, D. (2003) · Seminars in Oncology · doi:10.1016/s0093-7754(03)00346-4 · Cited by 140 · see citing works
Cox, E. A., Bennin, D. A., Doan, A. T., O’Toole, T. E., & Anna Huttenlocher, A. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-03-0142 · Cited by 139 · see citing works
Androgen Receptor Cross-talk with Cell Signalling Pathways
Čulig, Z. (2004) · Growth Factors · doi:10.1080/08977190412331279908 · Cited by 137 · see citing works
RACK1 IS UP‐REGULATED IN ANGIOGENESIS AND HUMAN CARCINOMAS
Berns, H., Humar, R., Hengerer, B., Kiefer, F. N., & Battegay, E. J. (2000) · The FASEB Journal · doi:10.1096/fj.99-1038com · Cited by 119 · see citing works
Signal transduction in prostate cancer progression
Gioeli, D. G. (2005) · Clinical Science · doi:10.1042/cs20040329 · Cited by 116 · see citing works
Self-citationArnold, S. F., Melamed, M., Vorojeikina, D. P., Notides, A. C., & Sasson, S. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.1.9876 · Cited by 110 · see citing works
Vomastek, T., Schaeffer, H. J., Tarcsafalvi, A., Smolkin, M. E., Bissonette, E. A., & Weber, M. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305894101 · Cited by 109 · see citing works
Self-citationThe WD protein Rack1 mediates protein kinase C and integrin-dependent cell migration
Buensuceso, C. S., Woodside, D. G., Huff, J. L., Plopper, G. E., & O’Toole, T. E. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.9.1691 · Cited by 108 · see citing works
Усачева, А. М., Smith, R. L., Minshall, R. D., Baida, G. E., Seng, S., Croze, E., & Colamonici, O. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100087200 · Cited by 88 · see citing works
RACK1 Regulates G1/S Progression by Suppressing Src Kinase Activity
Mamidipudi, V., Zhang, J., Lee, K. C., & Cartwright, C. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6788-6798.2004 · Cited by 77 · see citing works
Rigas, A. C., Ozanne, D. M., Neal, D. E., & Robson, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306219200 · Cited by 64 · see citing works
Kuiper, G. G. J. M., & Brinkmann, A. O. (1995) · Biochemistry · doi:10.1021/bi00006a005 · Cited by 59 · see citing works
Haas, D., White, S., Lutz, L. B., Rasar, M., & Hammes, S. R. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0531 · Cited by 59 · see citing works
RACK1 regulates Src-mediated Sam68 and p190RhoGAP signaling
Miller, L. D., Lee, K. C., Mochly‐Rosen, D., & Cartwright, C. A. (2004) · Oncogene · doi:10.1038/sj.onc.1207735 · Cited by 41 · see citing works
Characterization of MNAR expression
Greger, J., Guo, Y., Henderson, R. A., Ross, J. F., & Cheskis, B. J. (2005) · Steroids · doi:10.1016/j.steroids.2005.09.016 · Cited by 31 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Androgen receptor: structure, role in prostate cancer and drug discovery
Tan, M.-H., Li, J., Xu, H. E., Melcher, K., & Yong, E. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.18 · Cited by 958 · see citing works
Molecular genetics of prostate cancer: new prospects for old challengesPreprint
Shen, M. M., & Abate-Shen, C. T. (2010) · Genes & Development · doi:10.1101/gad.1965810 · Cited by 949 · see citing works
Harris, W. P., Mostaghel, E. A., Nelson, P. S., & Montgomery, B. (2009) · Nature Clinical Practice Urology · doi:10.1038/ncpuro1296 · Cited by 880 · see citing works
Heemers, H. V., & Tindall, D. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0019 · Cited by 753 · see citing works
Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity
Berglund, E., Maaskola, J., Schultz, N., Friedrich, S., Marklund, M., Bergenstråhle, J., Tarish, F., Tanoglidi, A., Vicković, S., Larsson, L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04724-5 · Cited by 550 · see citing works
Androgen receptor signaling in prostate cancer development and progression
Tindall, D. J., & Lonergan, P. E. (2011) · Journal of Carcinogenesis · doi:10.4103/1477-3163.83937 · Cited by 544 · see citing works
RACK1, A multifaceted scaffolding protein: Structure and function
Adams, D. R., Dorit Ron, A., & Kiely, P. A. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-22 · Cited by 467 · see citing works
Androgen receptors in hormone-dependent and castration-resistant prostate cancer
Shafi, A. A., Yen, A. E., & Weigel, N. L. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.07.003 · Cited by 422 · see citing works
Targeting the androgen receptor pathway in prostate cancer
Chen, Y., Sawyers, C. L., & Scher, H. I. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.07.005 · Cited by 393 · see citing works
Yuan, X., Cai, C., Chen, S., Chen, S., Yu, Z., & Balk, S. P. (2013) · Oncogene · doi:10.1038/onc.2013.235 · Cited by 367 · see citing works
Mahajan, N. P., Liu, Y., Majumder, S., Warren, M. R., Parker, C. E., Mohler, J. L., Earp, H. S., & Whang, Y. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700420104 · Cited by 274 · see citing works
Mechanisms mediating androgen receptor reactivation after castration
Yuan, X., & Balk, S. P. (2008) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2008.03.021 · Cited by 204 · see citing works
Steroid Receptor Phosphorylation: A Key Modulator of Multiple Receptor Functions
Weigel, N. L., & Moore, N. L. T. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0101 · Cited by 196 · see citing works
RACK1, a versatile hub in cancer
Li, J., & Xie, D. (2014) · Oncogene · doi:10.1038/onc.2014.127 · Cited by 182 · see citing works
Minireview: Alternative Activation Pathways for the Androgen Receptor in Prostate Cancer
Lamont, K. R., & Tindall, D. J. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0469 · Cited by 150 · see citing works
miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT
Kao, C.-J., Martiniez, A., Shi, X.-B., Yang, J. C., Evans, C. P., Dobi, A., White, R. D., & Kung, H.-J. (2013) · Oncogene · doi:10.1038/onc.2013.200 · Cited by 147 · see citing works
Androgen deprivation of prostate cancer: Leading to a therapeutic dead end
Katzenwadel, A., & Wolf, P. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.06.021 · Cited by 140 · see citing works
Regulation of the androgen receptor by post-translational modifications
Coffey, K., & Robson, C. N. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0238 · Cited by 137 · see citing works
Post-translational modification of the androgen receptor
Gioeli, D. G., & Paschal, B. M. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.004 · Cited by 136 · see citing works
Self-citationCDK9 Regulates AR Promoter Selectivity and Cell Growth through Serine 81 Phosphorylation
Gordon, V. L., Bhadel, S., Wunderlich, W., Zhang, J., Ficarro, S. B., Mollah, S., Shabanowitz, J., Hunt, D. F., Xénarios, I., Hahn, W. C., et al. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0238 · Cited by 134 · see citing works
Self-citationPosttranslational Modification of the Androgen Receptor in Prostate Cancer
der Steen, T. V., Tindall, D. J., & Huang, H. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140714833 · Cited by 133 · see citing works
Molecular pathways and targets in prostate cancer
Shtivelman, E., Beer, T. M., & Evans, C. P. (2014) · Oncotarget · doi:10.18632/oncotarget.2406 · Cited by 115 · see citing works
Kaikkonen, S., Jääskeläinen, T. J., Karvonen, U., Rytinki, M. M., Makkonen, H., Gioeli, D. G., Paschal, B. M., & Palvimo, J. J. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0219 · Cited by 114 · see citing works
Self-citationLiu, Y., Karaca, M., Zhang, Z., Gioeli, D., Earp, H. S., & Whang, Y. E. (2010) · Oncogene · doi:10.1038/onc.2010.103 · Cited by 106 · see citing works
Self-citationFontana, F., Raimondi, M., Marzagalli, M., Domizio, A. D., & Limonta, P. (2020) · Cells · doi:10.3390/cells9020460 · Cited by 105 · see citing works
Kiely, P. A., Baillie, G. S., Barrett, R., Buckley, D. A., Adams, D. R., Houslay, M. D., & O’Connor, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.017640 · Cited by 102 · see citing works
Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer
Li, J., Cao, B., Liu, X., Fu, X., Xiong, Z., Chen, L., Sartor, O. A., Dong, Y., & Zhang, H. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0985 · Cited by 102 · see citing works
Invasive Prostate Carcinoma Driven by c-Src and Androgen Receptor Synergy
Cai, H., Babić, I., Wei, X. X., Huang, J., & Witte, O. N. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1605 · Cited by 96 · see citing works
Differential transformation capacity of Src family kinases during the initiation of prostate cancer
Cai, H., Smith, D. A., Memarzadeh, S., Lowell, C. A., Cooper, J. A., & Witte, O. N. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103904108 · Cited by 89 · see citing works
Effect of Ack1 tyrosine kinase inhibitor on ligand-independent androgen receptor activity.
Mahajan, K., Challa, S., Coppola, D., Lawrence, H., Luo, Y., Gevariya, H., Zhu, W., Chen, Y. A., Lawrence, N. J., & Mahajan, N. P. (2010) · The Prostate · doi:10.1002/pros.21163 · Cited by 86 · see citing works
RACK1: A superior independent predictor for poor clinical outcome in breast cancer
Cao, X., Xu, J., Liu, X., Xu, J., Wang, W., Li, Q., Chen, Q., Xu, Z., & Liu, X. (2009) · International Journal of Cancer · doi:10.1002/ijc.25120 · Cited by 84 · see citing works
Minireview: Tipping the Balance: Ligand-Independent Activation of Steroid Receptors
Bennesch, M. A., & Picard, D. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1315 · Cited by 80 · see citing works
Sicoli, D., Jiao, X., Ju, X., Velasco-Velázquez, M. A., Ertel, A., Addya, S., Li, Z., Andò, S., Fatatis, A., Paudyal, B., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0612 · Cited by 79 · see citing works
RACK1 promotes tumorigenicity of colon cancer by inducing cell autophagy
Xiao, T., Zhu, W., Huang, W., Lu, S., Li, X., Xiao, Z., & Yi, H. L. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1113-9 · Cited by 74 · see citing works
Kinases and protein phosphorylation as regulators of steroid hormone action
Weigel, N. L., & Moore, N. L. (2007) · Nuclear Receptor Signaling · doi:10.1621/nrs.05005 · Cited by 72 · see citing works
Androgen receptor‐related diseases: what do we know?
Shukla, G. C., Plaga, A. R., Shankar, E., & Gupta, S. (2016) · Andrology · doi:10.1111/andr.12167 · Cited by 72 · see citing works
Linn, D. E., Yang, X., Xie, Y., Alfano, A., Deshmukh, D., Wang, X., Shimelis, H., Chen, H., Li, W., Xu, K., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.338350 · Cited by 64 · see citing works
Zhou, Z., Liu, F., Zhang, Z.-S., Shu, F., Zheng, Y., Fu, L., & Li, L.-Y. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1027 · Cited by 61 · see citing works
Bhat, S. S., Anand, D., & Khanday, F. A. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0354-9 · Cited by 59 · see citing works
DaSilva, J. O., Gioeli, D. G., Weber, M. J., & Parsons, S. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4687 · Cited by 57 · see citing works
Self-citationStxbp4 Regulates ΔNp63 Stability by Suppression of RACK1-Dependent Degradation
Li, Y., Peart, M. J., & Prives, C. L. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00449-09 · Cited by 52 · see citing works
Oncogenic activation of androgen receptor
Kung, H.-J., & Evans, C. P. (2008) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2008.06.002 · Cited by 52 · see citing works
Cai, C., Portnoy, D. C., Wang, H., Jiang, X., Chen, S., & Balk, S. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0026 · Cited by 51 · see citing works
Targeting the androgen receptor signalling axis in castration‐resistant prostate cancer (CRPC)
Tsao, C., Galsky, M. D., Small, A., Yee, T., & Oh, W. K. (2012) · British Journal of Urology · doi:10.1111/j.1464-410x.2012.11445.x · Cited by 51 · see citing works
Identification of Kinases Regulating Prostate Cancer Cell Growth Using an RNAi Phenotypic Screen
Whitworth, H., Bhadel, S., Ivey, M. L., Conaway, M. R., Spencer, A., Hernan, R. A., Holemon, H., & Gioeli, D. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038950 · Cited by 50 · see citing works
Self-citationTargeting Tyrosine Kinases and Autophagy in Prostate Cancer
Kung, H.-J. (2010) · Hormones and Cancer · doi:10.1007/s12672-010-0053-3 · Cited by 50 · see citing works
Hu, R., Denmeade, S. R., & Luo, J. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.49 · Cited by 49 · see citing works
p66Shc—a longevity redox protein in human prostate cancer progression and metastasis
Rajendran, M., Thomes, P. G., Zhang, L., Veeramani, S., & Lin, M. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9213-8 · Cited by 48 · see citing works
Ramalingam, S., Ramamurthy, V. P., & Njar, V. C. O. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.07.006 · Cited by 48 · see citing works
Non-genomic signaling of steroid receptors in cancer
Thiébaut, C., Vlaeminck‐Guillem, V., Trédan, O., Poulard, C., & Romancer, M. L. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111453 · Cited by 47 · see citing works
Src: Marker or Actor in Prostate Cancer Aggressiveness
Vlaeminck‐Guillem, V., Gillet, G., & Rimokh, R. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00222 · Cited by 46 · see citing works
Li, H., Xie, N., Chen, R., Verreault, M., Fazli, L., Gleave, M. E., Barbier, O., & Dong, X. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1518 · Cited by 43 · see citing works
Barreiro-Alonso, A., Maceiras, M. L., Rodriguez-Belmonte, E. M., Vizoso‐Vázquez, Á., Quindós, M., & Cerdán, M. E. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/5845061 · Cited by 41 · see citing works
Wang, X., Zou, Z., Deng, Z., Liang, D., Zhou, X., Sun, R., & Lan, K. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006580 · Cited by 48 · see citing works
A novel role of Shc adaptor proteins in steroid hormone-regulated cancers
Alam, S. M., Rajendran, M., Ouyang, S., Veeramani, S., Zhang, L., & Lin, M.-F. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0179 · Cited by 39 · see citing works
Shih, J.-W., Wang, L., Hung, C.-L., Kung, H.-J., & Hsieh, C. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226138 · Cited by 36 · see citing works
Islas‐Flores, T., Guillén, G., Alvarado-Affantranger, X., Lara-Flores, M., Sánchez, F., & Villanueva, M. A. (2011) · Molecular Plant-Microbe Interactions · doi:10.1094/mpmi-11-10-0261 · Cited by 34 · see citing works
Gelman, I. H. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.8264 · Cited by 33 · see citing works
Wang, F., Osawa, T., Tsuchida, R., Yuasa, Y., & Shibuya, M. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02065.x · Cited by 31 · see citing works
v-Src Oncogene Induces Trop2 Proteolytic Activation via Cyclin D1
Ju, X., Jiao, X., Ertel, A., Casimiro, M. C., Sante, G. D., Deng, S., Li, Z., Rocco, A. D., Zhan, T., Hawkins, A., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3327 · Cited by 29 · see citing works
Törer, H., Aydın, E. B., & Sezgintürk, M. K. (2018) · Analytica Chimica Acta · doi:10.1016/j.aca.2018.04.031 · Cited by 27 · see citing works
Bahadır, E. B., & Sezgintürk, M. K. (2016) · The Analyst · doi:10.1039/c6an00694a · Cited by 26 · see citing works
The RNA-binding protein SERBP1 interacts selectively with the signaling protein RACK1
Bolger, G. B. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.03.001 · Cited by 26 · see citing works
O’Mahony, O. A., Steinkamp, M. P., Albertelli, M. A., Brogley, M. A., Rehman, H., & Robins, D. M. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0273 · Cited by 25 · see citing works
Tian, R., Tian, J., Zuo, X., Ren, S., Zhang, H., Liu, H., Wang, Z., Cui, Y., Niu, R., & Zhang, F. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06191-3 · Cited by 24 · see citing works
Burich, R. A., Holland, W. S., Vinall, R. L., Tepper, C. G., White, R. D., & Mack, P. C. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07826.x · Cited by 23 · see citing works
Dorff, T. B., Quinn, D. I., Pinski, J., Goldkorn, A., Sadeghi, S., Tsao-Wei, D. D., Groshen, S. G., Kühn, P., & Gross, M. E. (2019) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2019.02.010 · Cited by 20 · see citing works
Leung, K. K., Hause, R. J., Barkinge, J. L., Ciaccio, M. F., Chuu, C., & Jones, R. B. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.034876 · Cited by 20 · see citing works
Soares, T., Fernandes, S. A. F., Lima, M. L. S., Stumpp, T., Schoorlemmer, G. H. M., Lazari, M. F. M., & Porto, C. S. (2013) · Andrology · doi:10.1111/j.2047-2927.2013.00103.x · Cited by 18 · see citing works
Targeting Key Players of Neuroendocrine Differentiation in Prostate Cancer
Zamora, I., Freeman, M. R., Encı́o, I., & Rotinen, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813673 · Cited by 18 · see citing works
Shah, S., Hess-Wilson, J. K., Webb, S. L., Daly, H. K., Godoy‐Tundidor, S., Kim, J. I., Boldison, J., Daaka, Y., & Knudsen, K. E. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2166 · Cited by 16 · see citing works
Yang, L., Cui, M., Teng, H., WANG, F., YU, W., & Xu, T. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2274 · Cited by 15 · see citing works
Ghotbaddini, M., Cisse, K., Carey, A. E., & Powell, J. B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179844 · Cited by 15 · see citing works
Ma, L., Tian, Y., Tao, Q., Li, W., Liu, C., Chu, B., Kong, Q., Cai, R., Bai, P., Ma, L., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04945-z · Cited by 14 · see citing works
Martinez, H. D., Hsiao, J. J., Jasavala, R. J., Hinkson, I. V., Eng, J. K., & Wright, M. E. (2011) · Genes & Cancer · doi:10.1177/1947601912436422 · Cited by 14 · see citing works
Interaction of the Mineralocorticoid Receptor With RACK1 and Its Role in Aldosterone Signaling
Kuppusamy, M., Gómez-Sánchez, E. P., Beloate, L. N., Plonczynski, M. W., Náray‐Fejes‐Tóth, A., Fejes‐Tóth, G., & Gómez-Sánchez, C. E. (2017) · Endocrinology · doi:10.1210/en.2017-00095 · Cited by 14 · see citing works
Unveiling RACK1: a key regulator of the PI3K/AKT pathway in prostate cancer development
Lyu, C., Vaddi, P. K., Elshafae, S. M., Pradeep, A., Ma, D., & Chen, S. (2024) · Oncogene · doi:10.1038/s41388-024-03224-9 · Cited by 13 · see citing works
Yang, C.-C., Fazli, L., Loguercio, S., Zharkikh, I. L., Aza‐Blanc, P., Gleave, M. E., & Wolf, D. A. (2015) · Oncotarget · doi:10.18632/oncotarget.4279 · Cited by 12 · see citing works
Constitutive Aryl Hydrocarbon Receptor Signaling in Prostate Cancer Progression
Powell, J. B. (2018) · Journal of Cancer Treatment and Diagnosis · doi:10.29245/2578-2967/2018/5.1136 · Cited by 12 · see citing works
Silva, D. D., Zhang, Z., Liu, Y., Parker, J. S., Xu, C., Cai, L., Wang, G. G., Earp, H. S., & Whang, Y. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-55057-2 · Cited by 12 · see citing works
Si, J., Guo, R., Xiu, B., Chi, W., Zhang, Q., Hou, J., Su, Y., Chen, J., Xue, J., Shao, Z., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.927358 · Cited by 11 · see citing works
Zheng, Y., Zhang, L., Jia, X., Wang, H., & Hu, Y. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.12.013 · Cited by 11 · see citing works
Aydın, E. B., Aydın, M., & Sezgintürk, M. K. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113517 · Cited by 11 · see citing works
Koochekpour, S., Lee, T. ‐., Sun, Y., Hu, S., Grabowski, G. A., Liu, Z., & Garay, J. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21786 · Cited by 11 · see citing works
Li, C., Teng, T., Lin, X.-J., Sun, X., Yi, T., Wang, H., Gao, X., & Shen, K. (2025) · Cancer Research · doi:10.1158/0008-5472.can-25-1404 · Cited by 8 · see citing works
Kolosov, P. M., Biziaev, N., & Alkalaeva, E. Z. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311733 · Cited by 8 · see citing works
Ding, Y., Wang, X., Xu, A., Xu, X., Tian, K., Young, C. Y. F., & Yuan, H. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22977 · Cited by 8 · see citing works
Li, W., Araya, M., Elliott, M., Kang, X., Gerk, P. M., Halquist, M. S., Karnes, H. T., Zhang, C., & O'Brien, P. J. (2011) · Journal of Chromatography B · doi:10.1016/j.jchromb.2011.08.024 · Cited by 6 · see citing works
Inhibition of Fam114A1 protects melanocytes from apoptosis through higher RACK1 expression
Zhou, M., Lin, F., Wu, X., Ping, Z., Xu, W., Jin, R., & Xu, A. (2021) · Aging · doi:10.18632/aging.203712 · Cited by 4 · see citing works
Convergence of EGF Receptor and Src Family Signaling Networks in Cancer
Pritchard, J. E., Jablonski, A. B., & Parsons, S. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-356-1_9 · Cited by 4 · see citing works
Androgens Receptor Expression and Steroid Action in Bone
Wiren, K. M. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00062-8 · Cited by 4 · see citing works
Cell Biology of Prostate Cancer and Molecular Targets
Gleave, M. E., Cox, M., & Wang, Y. Z. (2010) · Springer eBooks · doi:10.1007/978-1-60327-829-4_1 · Cited by 3 · see citing works
Yang, J.-C., Du, Y.-Y., Zuo, W., Yao, J.-Y., Ma, K., Liang, Y. J., Zhao, M., & Li, Z.-M. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112519 · Cited by 2 · see citing works
Parsons, S. J., Pritchard, J. E., Fox, E. M., & Shupnik, M. A. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1764-4_3 · Cited by 2 · see citing works
Liu, J., Jiang, G., Yang, A., Yang, G., Yang, W., & Fang, Y. (2016) · PubMed Central · Cited by 2 · see citing works
Androgen Action in Bone: Basic Cellular and Molecular Aspects
Wiren, K. M. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-459-9_16 · Cited by 2 · see citing works
Liu, H., Wang, T., Cui, Y., Zhang, B., Shang, D., & Song, H. (2025) · Discover Oncology · doi:10.1007/s12672-025-03679-6 · Cited by 1 · see citing works
The Role of Cyclic AMP in Regulating the Androgen Receptor
Sadar, M. D. (2009) · Springer eBooks · doi:10.1007/978-0-387-69179-4_21 · Cited by 1 · see citing works
Role of androgen receptor co-repressor SLIRP in cell cycle regulation
De Silva, D. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/b7zq-dn70 · Cited by 1 · see citing works
Buoso, E., Serafini, M., Galasso, M., Ronfani, M., Poloni, L. M., Lanni, C., Corsini, E., & Racchi, M. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_116 · Cited by 1 · see citing works
- Authors
- Kraus, S., Gioeli, D., Vomastek, T., Gordon, V., & Weber, M. J.
- Affiliations
- University of Virginia Health System (US)
- Department of Microbiology and Cancer Center, University of Virginia Health System, Charlottesville, Virginia
- Venue
- Cancer Research
- Published
- 2006-11-15
- Volume
- 66
- Issue
- 22
- Pages
- 11047-11054
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2142284564
- Cited by
- 118
- References
- 42
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 5 · 2017: 5 · 2016: 6 · 2015: 7 · 2014: 12 · 2013: 5 · 2012: 5
- FWCI
- 7.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense (W81XWH)
- Prostate Cancer Foundation
- National Institutes of Health (W81XWH)
- National Cancer Institute (R01CA105402, P01CA104106)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Keywords
- androgen receptor, RACK1, Src kinase, tyrosine phosphorylation, prostate cancer, castration-resistant prostate cancer, adaptor proteins, signal transduction, growth factor receptor signaling, transcriptional activity
- MeSH terms
- Receptors for Activated C Kinase, Androgens, Animals, Chlorocebus aethiops, Humans, Male, Phosphorylation, Prostatic Neoplasms, Receptors, Androgen, Receptors, Cell Surface, Substrate Specificity, Signal Transduction, Disease Progression, src-Family Kinases, COS Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review